In theory, because both HAE and ACE inhibitor-associated angioedema are the results of excess bradykinin, icatibant should also be beneficial in the latter; however, two separate randomized clinical studies have determined there was no effect on the resolution of symptoms when caused by ACE inhibitors [1]. This evidence concerns the gene KNG1 and hereditary angioedema.